Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 123 participants.
Also called NCT02151812
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 123 participants
- Sponsor
- Hemoteq AG
- Registry
-
NCT02151812
-
- Other papers using this trial's data
- A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France, Germany
- Registry status
- Completed
Technical summary
Registry record NCT02151812. Randomized; single masking; primary purpose treatment. Start 2014-08-13 (actual); primary completion 2017-04-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Agent™ and SeQuent® Please Paclitaxel Coated Balloon Catheters in Coronary In-stent Restenosis (AGENT-ISR)
- Acronym
- AGENT-ISR
- Condition
- Coronary Artery Disease
- Condition
- Coronary Restenosis
- Condition
- Coronary Atherosclerosis
- Condition
- Coronary Arteriosclerosis
- Intervention (Device)
- Agent Paclitaxel-coated balloon
- Intervention (Device)
- SeQuent® Please Paclitaxel-coated Balloon
- Lead sponsor
- Hemoteq AG
Record details
- Record id
cardio:ct-nct02151812- Content hash
c9d38bd095013dba5124cf849340995d2f8d4a1a51ffd130c3f11cda20b88c40